identify new opportunities
ENGAGE WITH LEADS
Comparisons | Oncology ToolKit 2022 | Other Intelligence Sources |
|---|---|---|
Clinical Stage Oncology Drug Developers | 1235 Active Clinical Stage Companies (Companies with Active Pipeline are only Included) | 600-800 Companies (maybe mixed with non active/ diagnostic etc.) |
Pre-Clinical Stage Oncology Drug Developers | 1250 Active Preclinical Stage Companies (Well Funded with clear defined early stage Pipeline) | 400-600 Companies (with many inactive and other domain companies) |
Worldwide Coverage | 38 Countries Included (51% USA, 23% Europe, 21% Asia and 5% ROW) | Mainly United States and Europe Covered |
Oncology Drugs in Development | 4750+ Onco Targeting Drugs in Active Development(2700+ Clinical Stage with NCT Number & 2000+ Preclinical Stage, with their Targets and mechanism of Action) | 2000 – 2500 Onco Targeting Drugs (mainly includes Clinical Stage molecules in development) |
Bio-Partnering Details | 1700+ Oncology Deals complete details.(Complete coverage on Oncology focused Deals, Funding & Partnering Activities, since company’s incorporation) | Limited to Database / Resource Subscribed to.(Also it may require mapping of events between two or more different resources and filtering Onco Linked Deals). |
Single Step Connect | Over 12,000+ Key Decision Makers in aprox. 2500 Companies.(Manually Created and Validated Oncology Key Accounts CRM System with valid emails, contact no. and Social accounts details. | No Customized Solution Available in Market(Needs months of hard team work to prepare authentic business development tool. |
Trusted by
